- Home
- EMF vs ARAY Comparison
EMF vs ARAY Comparison
Compare EMF & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMF | ARAY |
|---|---|---|
| Founded | 1987 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.5M | 170.1M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | EMF | ARAY |
|---|---|---|
| Price | $17.56 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 29.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 6.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $10.58 | $0.91 |
| 52 Week High | $12.67 | $2.95 |
Technical Indicators
Market Signals| Indicator | EMF | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 43.83 |
| Support Level | $17.43 | $0.95 |
| Resistance Level | $17.78 | $1.13 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 82.44 | 60.98 |
Price Performance
Historical ComparisonAbout EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.